Latest News

Keep up to date with the latest news from Pilatus Biosciences.

News

April 2025

Pilatus Biosciences Publishes Preclinical Data in Cancer Discovery on PLT012 First-in-Class CD36-Targeting Antibody for Liver Cancer

April 2025

Pilatus Biosciences to Present Research on PLT012 at AACR 2025

November 2024

Pilatus Biosciences to Unveil Breakthrough Preclinical Data at SITC 2024: PLT012’s Transformative Potential in Liver Metastasis Treatment

November 2024

Pilatus Biosciences Inc. Receives Orphan Drug Designation from FDA for PLT012 in Treatment of Liver and Intrahepatic Bile Duct Cancer

Upcoming Events

Currently, there are no scheduled upcoming events.